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http://www.biomedcentral.com/1756-0500/7/664RESEARCH ARTICLE Open AccessAntioxidant activity of pomegranate juice reduces
acute lung injury secondary to hyperoxia in an
animal model
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and Marwan El Sabban3†Abstract
Background: Hyperoxia triggers the release of toxic reactive oxygen species (ROS). Pomegranate Juice (PJ) is a rich
source of potent antioxidants. We assessed the effects of PJ supplementation on Acute Lung Injury (ALI) in adult
rats exposed to hyperoxia for 5 days.
Methods: Adult rats were divided into four different groups: control, hyperoxia, hyperoxia + PJ and PJ. Animals
were placed in chambers containing either room air or oxygen above 95% for a total of 5 days. Two different PJ
concentrations were utilized and the control group received placebo water. Animals were euthanized and their
lungs were excised. Assessment of lung injury was accomplished by: a) wet to dry ratio (W/D) method,
b) measurement of albumin concentration in the bronchoalveolar lavage fluid (BALF), c) oxidative stress,
d) histological evaluation of the lung e) apoptosis and f) transcriptional expression levels of the inflammatory
mediators IL-1β, IL-6 and TNF-alpha.
Results: An increase in the W/D and albumin leak was noted in Hyperoxia (p < 0.05). Those findings were
attenuated by the higher dose of PJ supplementation. Hyperoxia increased ROS production. Again PJ
significantly reduced oxidative stress. Lung sections showed significant reduction in inflammation, edema,
and infiltrating neutrophils in Hyperoxia + 80 μmol/kg when compared with Hyperoxia. TUNEL demonstrated
significant apoptosis in the Hyperoxia, which was diminished in the Hyperoxia + 80 μmol/kg. Furthermore,
increase in IL-1β and IL-6 was noted in Hyperoxia. Again, 80 μmol/kg of PJ significantly reduced the expression
of inflammatory mediators.
Conclusion: In this animal model, PJ supplementation attenuated ALI associated with hyperoxia.
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Oxygen is frequently administered to patients with hyp-
oxia or in respiratory distress. Hyperoxia, on the other
hand, can also be detrimental and may worsen acute
lung injury (ALI) in patients with acute respiratory dis-
tress syndrome and in infants with bronchopulmonary
dysplasia [1,2]. The damaging effects of hyperoxia are
associated with excessive generation of hydroxyl radicals,* Correspondence: ah51@aub.edu.lb
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These reactive oxygen species (ROS) may oxidize nucleic
acids, membrane lipids and proteins leading to cellular
damage and death [4,5]. Further recruitment of neutro-
phils and infiltration of lung parenchyma is noted with
prolonged hyperoxia that will persist even after the ter-
mination of oxygen exposure [6]. Cellular defenses
against increased oxidative stress such as antioxidant en-
zymes and non-protein thiols become depleted by the
excess production of ROS instigating cellular injury and
death [7].
To prevent oxidative stress/imbalance noted in hyper-
oxia, antioxidant supplementation in animal models andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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et al. tested a catalytic antioxidant metalloporphyrin
(AEOL 10113) on fetal baboons receiving 100% oxygen.
AEOL 10113 supplementation was associated with a sig-
nificant reduction in the number of mast cells and eosin-
ophils infiltrating the lungs and a reduction in alveolar
septa thickness noted with hyperoxia [10]. Transgenic
neonatal mice expressing extra copy of extracellular
superoxide dismutase (EC-SOD) had a significant reduc-
tion in ROS and improved angiogenesis in neonatal mice
lung following exposure to hyperoxia, while EC-SOD
knocked out mice had reduced neovascularization, in-
creased endothelial dysfunction and worsening lung in-
jury when compared to controls [11,12]. The promising
data from animal studies have not translated to signifi-
cant results in human trails [13-15].
Punica granatum L. (Punicaceae), referred to as pom-
egranate, is commonly consumed as pomegranate juice (PJ).
It is well known that PJ possesses exceptional antioxidant,
antiatherogenic, antiproliferative and anti-inflammatory ef-
fects [16]. PJ contains bioactive compounds that are power-
ful antioxidants, particularly polyphenols. Punicalagins α
and β monomers are predominant ellagitannins responsible
for the antioxidant properties of PJ. In addition, the combin-
ation of punicalagins α and β with other phytochemicals
such as ellagic acid and its glycosylated derivatives synergis-
tically enhances the superior antioxidant properties of PJ
[17]. When compared to other polyphenol rich juices or
beverages, PJ has the highest antioxidant properties [18].
In this study, we examined the role of antioxidants,
represented by PJ, in attenuating the pathological and in-
flammatory parameters of ALI in an animal model ex-
posed to hyperoxia.
Methods
The study was reviewed and approved by the university
research board and the institutional animal care and use
committee of the American University Of Beirut. Two
month old Sprague–Dawley rats were distributed to lit-
ters of 12 of equal body weight and nested on softwood
shavings in plexiglas exposure chambers. Food and water
were made available ad libitum and lighting was pro-
vided on a 12-hr light/dark cycle. Room and chambers
temperature were maintained at 22-24°C. The chambers
were equipped with flow-through systems for controlling
the delivery of either medical oxygen or room air. In
chambers receiving oxygen, medical oxygen concentra-
tion was continuously monitored using an oxygen moni-
tor (Ohmeda 5120, Douisville, CO) and maintained at
95 ± 2%. Carbon dioxide (CO2) levels were maintained
at 0.3% by placing soda lime inside the chamber to ab-
sorb CO2. Air within the chamber was recycled after be-
ing passed through anhydrous calcium sulfate and silica
gel mixture to remove ammonia and moisture. Relativehumidity was maintained between 50% and 80%. Ani-
mals were divided into four different groups: control,
hyperoxia, hyperoxia + PJ and PJ. The last two groups
were repeated for two different concentrations of PJ
(PJ40 and PJ80).
PJ concentrate (Wonderful variety, POM Wonderful,
Los Angeles) was utilized in this study. Compared with
other commercially available PJ, this product is well stud-
ied and its antioxidant polyphenols are characterized and
verified [19]. The preparation of PJ is described by the
manufacturer and the dosage was extrapolated from previ-
ous studies [20]. Concentrated PJ was diluted in water and
administered in two different concentrations: a) 40 μmol
of polyphenols from PJ/kg of body weight (PJ40) and b)
80 μmol of polyphenols from PJ/kg of body weight (PJ80).
The appropriate dose of PJ was prepared daily and mixed
with the drinking water. Daily fluid intake was observed
for all animals. The other groups received placebo free
water. PJ or water supplementation was initiated two
weeks prior to hyperoxia and maintained throughout the
experiment. Animals were then exposed to either room air
or hyperoxia for a total of five days.
Animals were anesthetized with xylazine and ketamine.
The trachea was cannulated with polyethylene tubing. The
abdomen was opened and animals were exsanguinated by
severing the aorta. The diaphragm was dissected to allow
free lung expansion. Bronchoalveolar lavage fluid (BALF)
samples were obtained by clipping the left lower lobes and
lavaging the remaining lung lobes by slowly instilling
1.5 ml of warm PBS (Ca++ and Mg++ free, 37°C) and then
gently aspirating. This cycle was repeated three times. The
clipped left lower lobes were excised for pulmonary water
content evaluation. The left upper lobes were fixed in for-
malin for pathology examination, ROS and TUNEL assay.
The remaining right lobes were individually frozen in li-
quid nitrogen for RNA extraction and RT-PCR.
Assessment of ALI
Wet-to-dry lung weight
Left lower lobes were excised, weighed and then placed
in the oven at 90°C for 48 hours. The dry weight was ob-
tained and the W/D was calculated.
Bronchoalveolar lavage (BAL): cell count and albumin level
BALF was centrifuged (4020 rpm for 5mins at 25°C)
onditions and the supernatant was stored at −80°C. The
BAL cell pellet was resuspended in 1 ml of 0.9% NaCl,
and the total number of cells was determined by count-
ing cells on a hemocytometer. Differential cell counts
(400 cells per slide) were performed on cytospin-prepared
slides (Thermo Shandon, Pittsburgh, PA) stained with
Diff-Quik (Dade Behring, Newark, DE). Trypan blue was
utilized to exclude any sample that has less than 90% via-
bility of cells.
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urement. The concentration of albumin was determined
by an immune-turbidimetric assay using polyclonal anti-
albumin antibodies (Roche Applied Science, Indianapolis,
IN, USA). Agglutination, caused by antigen/antibody com-
plexes, was measured utilizing a Hitachi 912 Autoanalyser
(Roche Diagnostics, Basel, Switzerland).
Detection of superoxide production
Dihydroethydine (DHE) was used to localize superoxide
production. Briefly, lung tissues (5 μm thick) were ob-
tained from (n = 4) control, hyperoxia, hyperoxia + PJ and
PJ. Lung sections were incubated with DHE (10 μmol/L
dissolved in DMSO, incubated in light-protected humidi-
fied chamber at 37°C for 15 min). Sections were not
washed and directly visualized by fluorescence microscopy
(Zeiss 710 laser scanning confocal microscope).
Measurement of inflammatory mediators IL-1β, IL-6, and
TNF-alpha
Inflammatory mediators’ transcriptional levels were assessed
using reverse transcriptase- polymerase chain reaction
(RT-PCR) method. Total RNA was isolated from the lung
homogenates using the TRIZOL method (Invitrogen,
Carlsbad, CA, USA). Briefly, 1 ml of TRIZOL reagent was
used per 50 - 100 mg of tissue sample followed by chloro-
form extraction. RNA samples were precipitated and
stored at −80°C. RNA was quantified using a 260/280 nm
absorbance ratio method. Total RNA (1 μg) was reverse-
transcribed into first strand cDNA using a special kit
(Ready-to-go You-prime-Strand-Beads, GE healthcare,
UK). Real time-PCR was performed using the iCycler
(Bio-Rad laboratories, Hercules, CA, USA) with SYBR
Green. Specific primers (Tib-Molbiol, Berlin, Germany)
were utilized to assess the expression of inflammatory me-
diators in these tissues:
(IL-1β: Fw CACCTCTCAAGCAGAGCACAG, Rw GG
GTTCCATGGTGAAGTCAAC;
IL-6: Fw TCCTACCCCAACTTCCAATGCTC, Rw TT
GGATGGTCTTGGTCCTTAGCC;
TNF-α: Fw AATGGGCTCCCTCTCATCAGTTC, Rw
TCTGCTTGGTGGTTTGCTACGAC;
GAPDH: Fw GTATTGGGCGCCTGGTCACC, Rw CG
CTCCTGGAAGATGGTGATGG).
PCR products and their corresponding melting tem-
peratures were analyzed using the iQ5 Optical System
Software (Bio-Rad laboratories). Corrections for loading
were achieved by subtraction of local background and
normalization against the cDNA levels of the GAPDH
housekeeping gene.
Assessment of apoptosis
The Terminal deoxynucleotidyl transferase-mediated
dUTP Nick-End Labeling (TUNEL) assay was used tomonitor the extent of DNA fragmentation as a measure of
apoptosis in paraffin-embedded sections. The assay was
performed according to the recommendations of the
manufacturer (Boehringer, Mannheim, Germany). Paraffin
sections of 4 μm thick were used and Fluorescein-
conjugated dUTP incorporated in nucleotide polymers
were scanned for signal using 488 nm excitation line from
the Zeiss LSM 410 laser scanning confocal microscope.
Positive and negative controls were used to verify the spe-
cificity of the TUNEL assay. Positive controls were treated
with DNase I (Sigma Chemical Co. Saint-Louis, MI, USA)
to enzymatically induce DNA fragmentation. TUNEL-
positive nuclei were distinguished from the TUNEL-
negative nuclei by counter staining with Hoechst 33258
(Molecular Probes, Eugene, OR).
Pathologic evaluation of ALI
The upper lobe of the right lung was harvested and
immersed in 4% formaldehyde solution. The tissue was
then paraffin embedded, serially sectioned, and stained
with hematoxylin and eosin (H&E). Pulmonary morpho-
logic characteristics were evaluated as described before
[6]. Briefly, a pathologist, blinded to different animal
groups, evaluated the histopathologic findings under
light microscopy and determined the presence of lung
injury based on the following histological features: septal
edema, congestion, degree of inflammatory cell infiltra-
tion, and alveolar edema.
Statistical assessments
Differences were considered significant for p < 0.05 in
comparing two measurements. Comparison among
groups was evaluated by analysis of variance (ANOVA).
The Kruskall-Wallis test was used to compare apoptotic
index scores.
Results
There was no significant difference in the daily fluid in-
take of the different animal groups. An increase in mor-
tality in the hyperoxia only group (25%) and at the end
of the experiment, the remaining animals appeared ill
and lost weight.
Body weight, lung weight and W/D ratio
There was a statistically significant decrease in total
body weight (TBW) of animals exposed to hyperoxia
when compared to the control group (P = 0.009). Sup-
plementation with PJ (PJ40 and PJ80) failed to reverse
the loss of weight associated with hyperoxia (Figure 1A).
Likewise, animals exposed to hyperoxia demonstrated a
significant increase in mean total lung weight when com-
pared to the control group (P = 4.9 × 10−11) (Figure 1B).
There was no difference in mean W/D between the con-
























Figure 1 Mean total body weight (A), total lung weight (B), and W/D (C) of control, hyperoxia, hyperoxia + PJ40 and hyperoxia + PJ80.
Error bars represent SE. Sample size is eight per group. Asterisks indicate statistically significant associations (P < 0.05).
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significant increase in mean W/D noted in the hyperoxia
group when compared to the control group (P = 0.00004).
PJ supplementation did attenuate the increase in W/D
in the hyperoxia + PJ80 when compared to hyperoxia
(P = 0.0003) (Figure 1C).
Bronchoalveolar lavage: cell count and albumin level
A statistically significant increase in the number of RBC
and WBC was observed in hyperoxia when compared to
controls (P = 0.0001 and P = 0.03 respectively). The sup-
plementation of PJ to animals exposed to hyperoxia
demonstrated a trend in reducing the number of RBC
and WBC in BALF. This trend, however, didn’t reach a
statistical significance for both PJ doses utilized in this
study. Upon examination of BALF slides, we have ob-
served an increase in cellularity and neutrophil abun-
dance in hyperoxic groups. This was decreased but not
completely recovered upon administration of POM in a
dose dependendant manner.
Albumin leak in BALF increased significantly with
hyperoxia (P = 0.0005) when compared to the control
group. When compared to hyperoxia, albumin leak was
significantly attenuated with the higher concentration of
PJ only (Hyperoxia + PJ80) (P = 0.004; Figure 2).
ROS generation
Control and PJ groups demonstrated low levels of the
oxidative stress. In response to hyperoxia, there was an
increase in fluorescence indicating that hyperoxia cre-
ated increased ROS production. In animals pre-treated
with PJ and exposed to hyperoxia, the amount of oxida-
tive stress was significantly lower than animals exposedFigure 2 Mean albumin level in the BALF of control, hyperoxia, hyper
size is eight per group. Asterisks indicate statistically significant associationsto hyperoxia and not different from the control groups.
This indicated that PJ supplementation preserved oxida-
tive balance and reduced the oxidative stress associated
with hyperoxia (Figure 3).
Inflammatory mediators
There was no difference in TNF-α expression between
control and PJ groups. In addition and after 5 days of
hyperoxia exposure, there was no significant increase in
TNF-α expression when compared to the control group
(Figure 4A). Likewise, there was no difference in IL-1β
expression between controls and PJ groups. The pres-
ence of hyperoxia, however, was associated with a statis-
tically significant increase in IL-1β expression when
compared to control group (P = 0.05; Figure 4B). The ad-
ministration of PJ in the presence of hyperoxia for both
concentrations (PJ40 and PJ80) attenuated the surge in
IL-1β (P = 0.03 and P = 0.02 respectively; Figure 4B). IL-
6 expression demonstrated a significant increase after
hyperoxia exposure when compared with controls. This
increased expression of IL-6 was significantly attenuated
in the hyperoxia + PJ80 but not in the hyperoxia + PJ40
as compared with the hyperoxia group (P = 0.03 and P =
0.5 respectively). Again, there was no difference in IL-6
expression between control and PJ groups (Figure 4C).
TUNEL assay for apoptosis
No differences in apoptotic indices were observed between
the control group and animals receiving PJ supplementa-
tion (40-μmol/kg and 80-μmol/kg). As noted before, the
hyperoxia group did demonstrate an increase in apoptosis
when compared with the control group [6]. Sections from
hyperoxia + PJ groups revealed a significant reduction inoxia + PJ40 and hyperoxia + PJ80. Error bars represent SE. Sample
(P < 0.05).
Figure 3 ROS detection in lung tissues. 5 μm thickness slides were incubated with Dihydroethidium (DHE) as described by the manufacturer.
Fluorescent images of ethidium-stained tissue were analyzed using Zeiss 710 laser scanning confocal microscope. ROS levels were induced in
hyperoxia treated animals. Levels of ROS were attenuated in lung tissues of PJ treated animals.
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apoptotic activity was more prominent in the Hyperoxia +
PJ80 group. Hoechst staining provided additional evidence
that apoptosis did occur with hyperoxia exposure and did
reverse in the Hyperoxia + PJ80 group as well (Figure 5).
Pathological examination
There were no significant pathological differences on
examination of the control and PJ groups. After 5 days
of hyperoxia, macroscopic examination revealed edema-
tous lungs with punctuate hemorrhage when compared
with the control group. Examination with H & E showed
that the hyperoxia group had significant interstitial and
alveolar wall thickening accompanied by congestion of
the capillary blood vessels and penetration of mono-
nuclear inflammatory cells, mostly macrophages and
neutrophils. Apoptotic bodies were also noted. By ad-
ministering PJ, the damaging effects of hyperoxia were
attenuated. There was a reduction interstitial wall edema
and vascular congestion. No significant recruitment of
inflammatory cells was noted and no apoptotic bodies
were observed (Figure 6). Hyperoxia + PJ80 resulted in a
protective effect against the pathologic changes associ-
ated with hyperoxia.
Discussion
Our study did demonstrate the systemic effects of hyper-
oxia in an animal model. There was an increase in mor-
tality in the hyperoxia only group and the remaining
animals appeared ill and lost weight. The lungs were
intensely affected as well. A significant increase in the
W/D ratio and in albumin leak into the BALF was asso-
ciated with hyperoxia. Hyperoxia was also associated
with an increase in florescence of DHE, suggestive of anincreased oxidative stress status of the lungs. This was
coupled with a surge in the expressions of IL-1β and
IL-6. Pathologically, alveolar and vascular congestion, in-
creased infiltration of mononuclear inflammatory cells
into lung parenchyma and increased apoptosis was also
observed. Our findings are similar to those reported by
others and us in the literature [21,22]. In a time course
animal study, Nagato et al. noted a significant increase
in the number of macrophages and neutrophils after
24 hours of hyperoxia. Superoxide dismutase activity
was decreased and glutathione/oxidized glutathione ratio
was also reduced [23]. Previously, we have reported a
surge of inflammatory mediators associated with hyper-
oxia that was also time dependent [6].
Pomegranate Juice supplementation reduced mortality
as animals receiving daily 80-μmol/kg of PJ survived
hyperoxia but continued to demonstrate significant
weight loss suggesting persistent systemic effects of
hyperoxia. In the lungs, PJ supplementation significantly
reduced the increase in the W/D ratio, and albumin leak
noted with hyperoxia. The increase in IL-1β and IL-6
noted with hyperoxia was significantly reduced as well.
Pathologically, there was a reduction in the alveolar and
vascular congestion and a significant reduction in the
number of inflammatory cells recruited to the lung. The
increase in oxidative stress noted with hyperoxia was re-
duced as well. We concluded that, in this animal model,
supplementation of PJ to animals exposed to 5 days of
hyperoxia significantly reduced the damaging effects of
hyperoxia noted in the hyperoxia only group.
Our results are encouraging amidst the increased dis-
content and skepticism at the role of antioxidants in
lung injury associated hyperoxia and at the role of anti-
oxidants in ALI in general. The disappointing results
AB
C
Figure 4 Transcriptional expression TNF-α (A), IL-6 (B) and IL-1β (C). Expression of inflammatory mediators was evaluated by real-time PCR
in animals of control, hyperoxia, hyperoxia + PJ40 and hyperoxia + PJ80. Sample size is eight per group. Bars represent SE. Asterisks indicate
statistically significant associations (P < 0.05).
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Figure 5 Apoptosis assessment. Terminal deoxynucleotidyl transferase- mediated dUTP nick-end labeling (TUNEL), Hoechst staining of lung
sections and overlay of TUNEL and Hoechst for control, PJ40, PJ80, hyperoxia, hyperoxia + PJ40 and hyperoxia + PJ80.
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poor choice of the specific antioxidant molecule, b) im-
proper timing and c) pathophysiology that is complex
and thus controlling one limb of the process may not
alter the ultimate progression of lung injury. The design
of this study played an essential role leading to thepositive results. The timing and the dose of antioxidant
proved critical. In our study, we initiated PJ supplemen-
tation two weeks prior to hyperoxia. At the time of in-
sult with hyperoxia, animals were adequately primed
with antioxidants leading to early and effective control
of oxidative stress/imbalance created by hyperoxia and
Figure 6 Hematoxylin and eosin examination under light microscopy. A & B, Normal rat lung showing thin interstitial alveolar wall and fine
capillary vessels. Rare inflammatory cells in the wall and intra-alveolar spaces are noted and minimal swelling around blood vessels. C & D After
five days of hyperoxia, thickening of the interstitial wall, capillary congestion and the inflammation is noted. At higher magnification, neutrophil
and the increased mononuclear inflammatory cells within the wall and the alveolar spaces are observed. E & F: With PJ supplementation, a
significant reduction in the thickness of the interstitial alveolar wall and the marked reduction in the number of inflammatory cells is noted.
There is now resemblance to normal tissue in A & B.
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portant inflammatory cascades/mediators leading to
ALI. In addition, we experimented with higher doses of
PJ and noted unwanted systemic effects (animals ap-
peared ill and lost weight) and lung injury was observed
in controls receiving massive doses of PJ supplementa-
tion (320 μmoles and 1000 μmoles). Excessively higher
doses of exogenous anti-oxidants may be associated with
significantly low levels of ROS leading to immunosup-
pression and possible infection [13]. Too much of the
good thing (i.e. antioxidants) can actually counterpro-
ductive and possibly toxic [24]. As for the choice of anti-
oxidants, we utilized PJ as an antioxidant rather than
utilizing a single molecule from the PJ mixture of anti-
oxidants. Choosing one specific antioxidant and expect-
ing it to resolve ALI as compared to the mix of
antioxidants noted in PJ may not be as effective and maybe the setup for failure. It appears that the different anti-
oxidants constituents of PJ exert synergistic effect cul-
minating in better control of oxidative stress [25].
Finally and due to the additional anti-inflammatory ef-
fects of PJ, we cannot rule out other pathways that were
affected by PJ culminating in limiting the damaging ef-
fects of hyperoxic exposure in this animal model.
Conclusion
Prolonged hyperoxia is documented to induce ALI,
which is thought to be secondary to excessive ROS
production. In this study using an animal model of
hyperoxia induced ALI, PJ supplementation reduced
ROS production, decreased inflammation, apoptosis,
neutrophil infiltration of lung parenchyma and the surge
in the expression of inflammatory mediators observed
with hyperoxia.
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